CDK12: a potential therapeutic target in cancer

被引：25

作者：

Emadi, Fatemeh ^{[1
]}

Teo, Theodosia ^{[1
]}

Rahaman, Muhammed H. ^{[1
]}

Wang, Shudong ^{[1
]}

机构：

[1] Univ South Australia, UniSA Clin & Hlth Sci, Drug Discovery & Dev, Adelaide, SA 5000, Australia

来源：

DRUG DISCOVERY TODAY | 2020年 / 25卷 / 12期

关键词：

D O I：

10.1016/j.drudis.2020.09.035

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cyclin-dependent kinase (CDK) 12 engages in diversified biological functions, from transcription, post-transcriptional modification, cell cycle, and translation to cellular proliferation. Moreover, it regulates the expression of cancer-related genes involved in DNA damage response (DDR) and replication, which are responsible for maintaining genomic stability. CDK12 emerges as an oncogene or tumor suppressor in different cellular contexts, where its dysregulation results in tumorigenesis. Current CDK12 inhibitors are nonselective, which impedes the process of pharmacological target validation and drug development. Herein, we discuss the latest understanding of the biological roles of CDK12 in cancers and provide molecular analyses of CDK12 inhibitors to guide the rational design of selective inhibitors.

引用

页码：2257 / 2267

页数：11

共 120 条

[51] CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263 [J].

Huang, Tianlu ;

Ding, Xiwei ;

Xu, Guifang ;

Chen, Gang ;

Cao, Yu ;

Peng, Chunyan ;

Shen, Shanshan ;

Lv, Ying ;

Wang, Lei ;

Zou, Xiaoping .

CELL DEATH & DISEASE, 2019, 10 (8)

[52] Key signaling nodes in mammary gland development and cancer: β-catenin [J].

Incassati, Angela ;

Chandramouli, Anupama ;

Eelkema, Rachel ;

Cowin, Pamela .

BREAST CANCER RESEARCH, 2010, 12 (06)

[53] EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma [J].

Iniguez, Amanda Balboni ;

Stolte, Bjoern ;

Wang, Emily Jue ;

Conway, Amy Saur ;

Alexe, Gabriela ;

Dharia, Neekesh V. ;

Kwiatkowski, Nicholas ;

Zhang, Tinghu ;

Abraham, Brian J. ;

Mora, Jaume ;

Kalev, Peter ;

Leggett, Alan ;

Chowdhury, Dipanjan ;

Benes, Cyril H. ;

Young, Richard A. ;

Gray, Nathanael S. ;

Stegmaier, Kimberly .

CANCER CELL, 2018, 33 (02) :202-+

[54] Structure-Based Design of Selective Noncovalent CDK12 Inhibitors [J].

Johannes, Jeffrey W. ;

Denz, Christopher R. ;

Su, Nancy ;

Wu, Allan ;

Impastato, Anna C. ;

Mlynarski, Scott ;

Varnes, Jeffrey G. ;

Prince, D. Bryan ;

Cidado, Justin ;

Gao, Ning ;

Haddrick, Malcolm ;

Jones, Natalie H. ;

Li, Shaobin ;

Li, Xiuwei ;

Liu, Yang ;

Nguyen, Toan B. ;

O'Connell, Nichole ;

Rivers, Emma ;

Robbins, Daniel W. ;

Tomlinson, Ronald ;

Yao, Tieguang ;

Zhu, Xiahui ;

Ferguson, Andrew D. ;

Lamb, Michelle L. ;

Manchester, John I. ;

Guichard, Sylvie .

CHEMMEDCHEM, 2018, 13 (03) :231-235

[55] CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer [J].

Johnson, Shawn F. ;

Cruz, Cristina ;

Greifenberg, Ann Katrin ;

Dust, Sofia ;

Stover, Daniel G. ;

Chi, David ;

Primack, Benjamin ;

Cao, Shiliang ;

Bernhardy, Andrea J. ;

Coulson, Rhiannon ;

Lazaro, Jean-Bernard ;

Kochupurakkal, Bose ;

Sun, Heather ;

Unitt, Christine ;

Moreau, Lisa A. ;

Sarosiek, Kristopher A. ;

Scaltriti, Maurizio ;

Juric, Dejan ;

Baselga, Jose ;

Richardson, Andrea L. ;

Rodig, Scott J. ;

D'Andrea, Alan D. ;

Balmana, Judith ;

Johnson, Neil ;

Geyer, Matthias ;

Serra, Violeta ;

Lim, Elgene ;

Shapiro, Geoffrey I. .

CELL REPORTS, 2016, 17 (09) :2367-2381

[56] Ovarian Cancer-associated Mutations Disable Catalytic Activity of CDK12, a Kinase That Promotes Homologous Recombination Repair and Resistance to Cisplatin and Poly(ADP-ribose) Polymerase Inhibitors [J].

Joshi, Poorval M. ;

Sutor, Shari L. ;

Huntoon, Catherine J. ;

Karnitz, Larry M. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (13) :9247-9253

[57] BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents [J].

Kanakkanthara, Arun ;

Kurmi, Kiran ;

Ekstrom, Thomas L. ;

Hou, Xiaonan ;

Purfeerst, Emma R. ;

Heinzen, Ethan P. ;

Correia, Cristina ;

Huntoon, Catherine J. ;

O'Brien, Daniel ;

Hendrickson, Andrea E. Wahner ;

Dowdy, Sean C. ;

Li, Hu ;

Oberg, Ann L. ;

Hitosugi, Taro ;

Kaufmann, Scott H. ;

Weroha, S. John ;

Karnitz, Larry M. .

CANCER RESEARCH, 2019, 79 (23) :5920-5929

[58] Extracellular Vesicle Delivery of TRAIL Eradicates Resistant Tumor Growth in Combination with CDK Inhibition by Dinaciclib [J].

Ke, Changhong ;

Hou, Huan ;

Li, Jiayu ;

Su, Kui ;

Huang, Chaohong ;

Lin, Yue ;

Lu, Zhiqiang ;

Du, Zhiyun ;

Tan, Wen ;

Yuan, Zhengqiang .

CANCERS, 2020, 12 (05)

[59]

Ko TK, 2001, J CELL SCI, V114, P2591

[60] CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation [J].

Krajewska, Malgorzata ;

Dries, Ruben ;

Grassetti, Andrew, V ;

Dust, Sofia ;

Gao, Yang ;

Huang, Hao ;

Sharma, Bandana ;

Day, Daniel S. ;

Kwiatkowski, Nicholas ;

Pomaville, Monica ;

Dodd, Oliver ;

Chipumuro, Edmond ;

Zhang, Tinghu ;

Greenleaf, Arno L. ;

Yuan, Guo-Cheng ;

Gray, Nathanael S. ;

Young, Richard A. ;

Geyers, Matthias ;

Gerber, Scott A. ;

George, Rani E. .

NATURE COMMUNICATIONS, 2019, 10 (1)

← 1 2 3 4 5 6 7 8 9 10 →